UBS AM’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-371,681
| Closed | -$31.6M | – | 2621 |
|
|
2020
Q3 | $31.6M | Sell |
371,681
-2,656
| -0.7% | -$134K | 0.02% | 644 |
|
|
2020
Q2 | $13.3M | Sell |
374,337
-192,600
| -34% | -$5.63M | 0.01% | 843 |
|
|
2020
Q1 | $7.64M | Sell |
566,937
-80,831
| -12% | -$1.36M | 0.01% | 932 |
|
|
2019
Q4 | $13.7M | Sell |
647,768
-660,537
| -50% | -$11.7M | 0.01% | 860 |
|
|
2019
Q3 | $17.3M | Buy |
1,308,305
+21,053
| +2% | +$309K | 0.01% | 797 |
|
|
2019
Q2 | $17.9M | Buy |
1,287,252
+189,241
| +17% | +$2.85M | 0.01% | 789 |
|
|
2019
Q1 | $21.1M | Buy |
1,098,011
+371,053
| +51% | +$5.98M | 0.02% | 730 |
|
|
2018
Q4 | $10.4M | Buy |
726,958
+65,717
| +10% | +$1.3M | 0.01% | 861 |
|
|
2018
Q3 | $13.8M | Sell |
661,241
-23,616
| -3% | -$559K | 0.01% | 856 |
|
|
2018
Q2 | $16.2M | Buy |
684,857
+606,701
| +776% | +$12.2M | 0.01% | 817 |
|
|
2018
Q1 | $1.14M | Buy |
78,156
+13,007
| +20% | +$213K | ﹤0.01% | 1732 |
|
|
2017
Q4 | $1.05M | Buy |
65,149
+29,238
| +81% | +$345K | ﹤0.01% | 1730 |
|
|
2017
Q3 | $502K | Buy |
35,911
+678
| +2% | +$6.76K | ﹤0.01% | 1945 |
|
|
2017
Q2 | $311K | Sell |
35,233
-32,068
| -48% | -$225K | ﹤0.01% | 2025 |
|
|
2017
Q1 | $435K | Buy |
67,301
+52,709
| +361% | +$267K | ﹤0.01% | 1909 |
|
|
2016
Q4 | $54K | Sell |
14,592
-21,100
| -59% | -$62.4K | ﹤0.01% | 2303 |
|
|
2016
Q3 | $116K | Hold |
35,692
| – | – | ﹤0.01% | 2558 |
|
|
2016
Q2 | $83K | Sell |
35,692
-10,200
| -22% | -$34.1K | ﹤0.01% | 2593 |
|
|
2016
Q1 | $115K | Hold |
45,892
| – | – | ﹤0.01% | 2550 |
|
|
2015
Q4 | $141K | Hold |
45,892
| – | – | ﹤0.01% | 2616 |
|
|
2015
Q3 | $79K | Buy |
45,892
+10,200
| +29% | +$26K | ﹤0.01% | 2633 |
|
|
2015
Q2 | $145K | Buy |
35,692
+2,300
| +7% | +$9.4K | ﹤0.01% | 2641 |
|
|
2015
Q1 | $128K | Buy |
33,392
+2,400
| +8% | +$10.4K | ﹤0.01% | 2565 |
|
|
2014
Q4 | $149K | Hold |
30,992
| – | – | ﹤0.01% | 2527 |
|
|
2014
Q3 | $115K | Hold |
30,992
| – | – | ﹤0.01% | 2493 |
|
|
2014
Q2 | $113K | Hold |
30,992
| – | – | ﹤0.01% | 2519 |
|
|
2014
Q1 | $130K | Buy |
30,992
+5,900
| +24% | +$29.3K | ﹤0.01% | 2520 |
|
|
2013
Q4 | $115K | Hold |
25,092
| – | – | ﹤0.01% | 2487 |
|
|
2013
Q3 | $155K | Hold |
25,092
| – | – | ﹤0.01% | 2399 |
|
|
2013
Q2 | $137K | Buy |
+25,092
| New | +$82.4K | ﹤0.01% | 2351 |
|
UBS AM's IMMU Position: Q4 2020 in Review
UBS AM sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 371,681 shares — an estimated $31.6M sold.
UBS AM first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $31.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- UBS AM reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- UBS AM sold 371,681 Immunomedics Inc shares in Q4 2020, an estimated $31.6M.
- UBS AM first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- UBS AM's Immunomedics Inc position peaked at $31.6M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on UBS AM's 13F filing for Q4 2020, filed 17 Feb 2021.